Full-text resources of PSJD and other databases are now available in the new Library of Science.
Visit https://bibliotekanauki.pl

PL EN


Preferences help
enabled [disable] Abstract
Number of results

Journal

2012 | 7 | 2 | 262-268

Article title

Safety and efficacy of exercise testing with atropine in patients with recent uncomplicated ST elevation acute myocardial infarction

Content

Title variants

Languages of publication

EN

Abstracts

EN

Publisher

Journal

Year

Volume

7

Issue

2

Pages

262-268

Physical description

Dates

published
1 - 4 - 2012
online
3 - 2 - 2012

Contributors

  • Division of Cardiology, Buccheri La Ferla Fatebenefratelli Hospital, Palermo, Italy
author
  • Division of Cardiology, Buccheri La Ferla Fatebenefratelli Hospital, Palermo, Italy
  • Division of Cardiology, Buccheri La Ferla Fatebenefratelli Hospital, Palermo, Italy
  • Division of Cardiology, Buccheri La Ferla Fatebenefratelli Hospital, Palermo, Italy
  • Division of Cardiology, Buccheri La Ferla Fatebenefratelli Hospital, Palermo, Italy
  • Division of Cardiology, Buccheri La Ferla Fatebenefratelli Hospital, Palermo, Italy
  • Division of Cardiology “P. Borsellino” G.F. Ingrassia Hospital, Palermo, Italy
author
  • Districtual Cardiology ASL 6, Palermo, Italy
  • Districtual Cardiology ASL 6, Palermo, Italy
  • Department of Internal Medicine, University of Palermo, Palermo, Italy
  • Division of Cardiology “P. Borsellino” G.F. Ingrassia Hospital, Palermo, Italy

References

  • [1] Gibbons RJ, Balady GJ, Timothy Bricker J, Chaitman BR, Fletcher GF, Froelicher VF et al. ACC/AHA 2002 Guideline Update for Exercise Testing: Summary Article. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines), Circulation 2002; 106; 1883–1892 http://dx.doi.org/10.1161/01.CIR.0000034670.06526.15[Crossref]
  • [2] Primeau M. Taillefer R, Essiambre R, Lambert R, Honos G. Technetium 99m Sestamibi myocardial perfusion imaging: comparison between treadmill, dipyridamole and trans-oesophageal atrial pacing “stress” tests in normal subjects, Eur J Nucl Med 1991; 18: 247–251 http://dx.doi.org/10.1007/BF00186648[Crossref]
  • [3] Brown KA, Rowen M. Impact of antianginal medications, peak heart rate and stress level on the prognostic value of a normal exercise myocardial perfusion imaging study, J Nucl Med 1993; 34: 1467–1471
  • [4] Verzijlbergen JF, Vermeersch PHMJ, Laarman G, Ascoop CAPL. Inadequate exercise leads to suboptimal imaging. Thallium-201 myocardial perfusion imaging after dipyridamole combined with low-level exercise unmasks ischemia in symptomatic patients with non diagnostic thallium-201 scan who exercise submaximally, J Nucl Med 1991; 32: 2071–2078
  • [5] McLaughlin PR, Martin RP, Doherty P et al. Reproducibility of thallium-201 myocardial imaging, Circulation 1977; 55: 497–503
  • [6] Manganelli F, Spadafora M, Varrella P et al. Addition of atropine to submaximal exercise stress testing in patients evaluated for suspected ischemia with SPECT imaging: a randomized placebo-controlled trial, Eur J Nucl Med Mol Imaging 2011; 38: 245–251 http://dx.doi.org/10.1007/s00259-010-1641-8[Crossref]
  • [7] Gibbons RJ, Balady GJ, Beasley JW et al. ACC/AHA guidelines for exercise testing, J Am Coll Cardiol 1997; 30: 260–3111 http://dx.doi.org/10.1016/S0735-1097(97)00150-2[Crossref]
  • [8] Iskandrian AS, Heo J, Kong B, Lyons E. The effect of exercise level on the ability of thallium-201 tomographic imaging in detecting coronary artery disease: analysis of 461 patients, J Am Coll Cardiol 1989; 14: 1477–1486 http://dx.doi.org/10.1016/0735-1097(89)90385-9[Crossref]
  • [9] Gauri AJ, Raxwal VK, Roux L et al. Effects of chronotropic incompetence and beta-blocker use on the exercise treadmill test in men, Am Heart J 2001; 142: 136–141 http://dx.doi.org/10.1067/mhj.2001.115788[Crossref]
  • [10] White MP. Pharmacologic stress testing: understanding the options, J Nucl Cardiol 1999; 6: 672–675 hyperactivity?), Circulation 1996; 93: 1485–1487 [Crossref]
  • [11] Sarullo FM, Schicchi R, Schirò M et al. Comparative evaluation of dobutamine-atropine stress echocardiography with exercise testing for detection of coronary artery disease [in Italian], G Ital Cardiol 1996; 26: 1279–1290
  • [12] McNeill AJ, Fioretti PM, el-Said SM et al. Enhanced sensitivity for detection of coronary artery disease by addition of atropine to dobutamine stress echocardiography, Am J Cardiol 1992; 70: 41–46 http://dx.doi.org/10.1016/0002-9149(92)91387-J[Crossref][WoS]
  • [13] Secknus MA, Marwick TH. Evolution of dobutamine echocardiography protocols and indications: safety and side effects in 3011 studies over 5 years, J Am Coll Cardiol 1997; 29: 1234–1240 http://dx.doi.org/10.1016/S0735-1097(97)00039-9
  • [14] Geleijnse ML, Elhendy A, van Domburg RT et al. Cardiac imaging for risk stratification with dobutamine -atropine stress testing in patients with chest pain: echocardiography, perfusion scintigraphy, or both?, Circulation 1997; 96: 137–147 [Crossref]
  • [15] Elhendy A, Valkema R, van Domburg RT et al. Safety of dobutamine-atropine stress myocardial perfusion scintigraphy, J Nucl Med 1998; 39: 1662–1666 [PubMed]
  • [16] Elhendy A, van Domburg RT, Bax JJ et al. The functional significance of chronotropic incompetence during dobutamine stress test, Heart 1999; 81: 398–403 [Crossref]
  • [17] Geleijnse ML, Elhendy A, Fioretti PM, Roelandt JRTC. Dobutamine stress myocardial perfusion imaging, Am Coll Cardiol 2000; 36: 2017–2027 http://dx.doi.org/10.1016/S0735-1097(00)01012-3[Crossref]
  • [18] Elhendy A, van Domburg RT, Bax JJ et al. Safety, hemodynamic profile, and feasibility of dobutamine stress technetium myocardial perfusion single- photon emission CT imaging for evaluation of coronary artery disease in the elderly, Chest 2000; 117: 649–656 http://dx.doi.org/10.1378/chest.117.3.649[Crossref]
  • [19] Ellestad MH, Wan MK. Predictive implications of stress testing: follow-up of 2700 subjects after maximum treadmill stress testing, Circulation 1975; 51: 363–369
  • [20] Myers J, Prakash M, Froelicher V. Do D, Partington S, Atwood JE. Exercise capacity and mortality among men referred for exercise testing, N Engl J Med 2002; 3546: 793–801 http://dx.doi.org/10.1056/NEJMoa011858[Crossref]
  • [21] Ledenheim ML, Pollock BH, Rozanshi A et al. Extent and severity of myocardial hypoperfusion as predictors of prognosis in patients with suspected coronary artery disease, J Am Coll Cardiol 1986; 7: 464–471 http://dx.doi.org/10.1016/S0735-1097(86)80454-5[Crossref]
  • [22] Hachamovitch R, Berman DS, Kiat H et al. Exercise myocardial perfusion SPECT in patients without known coronary artery disease. Incremental prognostic value and use in risk stratification, Circulation 1996; 93: 905–914 [Crossref]
  • [23] Schinkel AF, Elhendy A, van Domburg RT. Prognostic value of dobutamine-atropine stress (99m) Tc-tetrofosmin myocardial perfusion SPECT in patients with known or suspected coronary artery disease, J Nucl Med 2002; 43: 767–772
  • [24] Tsutsui JM, Osorio AFF, Lario FC et al. Comparison of safety and efficacy of the early injection of atropine during dobutamine stress echocardiography with the conventional protocol, Am J Cardiol 2004; 94: 1367–1372 http://dx.doi.org/10.1016/j.amjcard.2004.07.141[Crossref]
  • [25] Caner B, Karanfil A, Uysal U. Effect of an additional atropine injection during dobutamine infusion for myocardial SPECT, Nucl Med Commun 1997; 18: 567–573 http://dx.doi.org/10.1097/00006231-199706000-00012[Crossref]
  • [26] Sarullo FM, Ventimiglia C, Taormina A et al. Safety and feasibility of atropine added in patients with sub-maximal heart rate during exercise myocardial perfusion SPECT, Int J Cardiovasc Imaging 2007; 23: 511–518 http://dx.doi.org/10.1007/s10554-006-9169-5[Crossref]
  • [27] David D, Lang RM, Borow KM. Clinical utility of exercise, pacing, and pharmacologic stress testing for the noninvasive determination of myocardial contractility and reserve, Am Heart J 1988; 116: 235–247 http://dx.doi.org/10.1016/0002-8703(88)90284-0[Crossref]
  • [28] Katzung BG. Basic and clinical pharmacology, New York: Lange Medical, McGraw-Hill; 2001 p. 115
  • [29] Variola A, Albiero R, Dander B, Buonanno C. Exercise testing with atropine [in Italian], G Ital Cardiol 1997; 27: 255–262
  • [30] Munagala VK, Guduguntla V, Kasravi B, Cummings G, Gardin JM. Use of atropine in patients with chronotropic incompetence and poor exercise capacity during treadmill stress testing, Am Heart J 2003; 145: 1046–1050 http://dx.doi.org/10.1016/S0002-8703(02)94703-4[Crossref]

Document Type

Publication order reference

Identifiers

YADDA identifier

bwmeta1.element.-psjd-doi-10_2478_s11536-012-0001-4
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.